|
US6623744B2
(en)
*
|
1995-06-22 |
2003-09-23 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
CA2224798A1
(en)
|
1995-06-22 |
1997-01-09 |
Matthew T. Scholz |
Stable hydroalcoholic compositions
|
|
JP4497559B2
(ja)
*
|
1995-06-22 |
2010-07-07 |
スリーエム カンパニー |
安定なヒドロアルコール組成物
|
|
US7566460B2
(en)
*
|
1995-06-22 |
2009-07-28 |
3M Innovative Properties Company |
Stable hydroalcoholic compositions
|
|
US6440980B1
(en)
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
|
US6582711B1
(en)
|
1997-01-09 |
2003-06-24 |
3M Innovative Properties Company |
Hydroalcoholic compositions thickened using polymers
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
MXPA00012844A
(es)
*
|
1998-07-07 |
2004-05-21 |
Transdermal Technologies Inc |
Composiciones para la liberacion transdermica rapida y sin irritacion de agentes farmaceuticamente activos y metodos para formular tales composiciones y liberar los mismos.
|
|
EP1105096B1
(en)
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
KR100390870B1
(ko)
*
|
1999-02-09 |
2003-07-10 |
주식회사 삼양사 |
경피투여용 항구토제 조성물 및 이를 포함하는 제제
|
|
ES2261178T3
(es)
*
|
1999-02-09 |
2006-11-16 |
Samyang Corporation |
Una composicion transdermal de un agente anti-vomito y una preparacion de la misma.
|
|
US6679870B1
(en)
*
|
1999-07-23 |
2004-01-20 |
Vasca, Inc. |
Methods and kits for locking and disinfecting implanted catheters
|
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
|
US6582724B2
(en)
*
|
1999-12-16 |
2003-06-24 |
Dermatrends, Inc. |
Dual enhancer composition for topical and transdermal drug delivery
|
|
US6562368B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
|
|
US6558695B2
(en)
*
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
|
US6562370B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6586000B2
(en)
*
|
1999-12-16 |
2003-07-01 |
Dermatrends, Inc. |
Hydroxide-releasing agents as skin permeation enhancers
|
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
|
US6719997B2
(en)
|
2000-06-30 |
2004-04-13 |
Dermatrends, Inc. |
Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
|
|
US6562369B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
|
US6602912B2
(en)
|
2000-06-30 |
2003-08-05 |
Dermatrends, Inc. |
Transdermal administration of phenylpropanolamine
|
|
US6645520B2
(en)
|
1999-12-16 |
2003-11-11 |
Dermatrends, Inc. |
Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
|
|
US6673363B2
(en)
*
|
1999-12-16 |
2004-01-06 |
Dermatrends, Inc. |
Transdermal and topical administration of local anesthetic agents using basic enhancers
|
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US20030139384A1
(en)
*
|
2000-08-30 |
2003-07-24 |
Dudley Robert E. |
Method for treating erectile dysfunction and increasing libido in men
|
|
SE0004750D0
(sv)
|
2000-12-19 |
2000-12-19 |
Astrazeneca Ab |
Novel formulation
|
|
WO2003015678A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Lavipharm Laboratories Inc. |
Composition and transdermal drug delivery device
|
|
NO20014746D0
(no)
*
|
2001-09-28 |
2001-09-28 |
Clas M Kjoelberg |
Smertelindrende middel
|
|
WO2003032915A2
(en)
*
|
2001-10-16 |
2003-04-24 |
Avanir Pharmacueticals |
Viral inhibition by n-docosanol
|
|
DE10154324A1
(de)
*
|
2001-11-06 |
2003-08-07 |
Merz Pharma Gmbh & Co Kgaa |
Topisch applizierbare Zusammensetzungen mit externer Wirkstoffdepotbildung, deren Herstellung sowie deren Verwendung
|
|
TWI339122B
(en)
*
|
2002-03-15 |
2011-03-21 |
Lab Besins Iscovesco |
Androgen pharmaceutical composition,kit containing the same and method for using the same
|
|
MY139721A
(en)
*
|
2002-04-19 |
2009-10-30 |
Cpex Pharmaceuticals Inc |
Pharmaceutical composition
|
|
US20040018163A1
(en)
*
|
2002-04-29 |
2004-01-29 |
Wei Yu |
Cosmetic compositions comprising at least one dimethicone, at least one linear hydrocarbon wax and at least one compatibilizing agent
|
|
US7192599B2
(en)
*
|
2002-06-03 |
2007-03-20 |
Mmp, Inc. |
Mattifying oil-in-water emulsion
|
|
US20050042182A1
(en)
*
|
2003-08-13 |
2005-02-24 |
Moshe Arkin |
Topical compositions of urea
|
|
US20050037040A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of urea and ammonium lactate
|
|
US20050036953A1
(en)
*
|
2003-08-13 |
2005-02-17 |
Moshe Arkin |
Topical compositions of ammonium lactate
|
|
US20050020552A1
(en)
*
|
2003-07-16 |
2005-01-27 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050042268A1
(en)
*
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
US20050025833A1
(en)
*
|
2003-07-16 |
2005-02-03 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
|
KR20060113907A
(ko)
*
|
2003-09-29 |
2006-11-03 |
에테나 헬스케어 인코포레이티드 |
높은 알코올 함량의 겔-유사 및 포옴 조성물
|
|
AU2005284908B2
(en)
|
2004-09-13 |
2011-12-08 |
Morningside Venture Investments Limited |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
DE102004062775A1
(de)
|
2004-12-21 |
2006-06-29 |
Stockhausen Gmbh |
Alkoholischer Pumpschaum
|
|
CN103417388A
(zh)
|
2005-03-07 |
2013-12-04 |
戴博全球保健有限公司 |
含有有机硅表面活性剂的高醇含量发泡组合物
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
|
US7651990B2
(en)
*
|
2005-06-13 |
2010-01-26 |
3M Innovative Properties Company |
Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
|
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
|
DK2450041T3
(en)
|
2005-10-12 |
2018-11-19 |
Unimed Pharmaceuticals Llc |
Enhanced testosterone gel for use in the treatment of hypogonadism
|
|
US20070148101A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Marcia Snyder |
Foamable alcoholic composition
|
|
US8167847B2
(en)
|
2006-06-22 |
2012-05-01 |
Excelsior Medical Corporation |
Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
|
|
EP1905302A1
(de)
|
2006-09-30 |
2008-04-02 |
Bayer CropScience AG |
Suspensionskonzentrate
|
|
US20080146672A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Denton Marcia Marye |
Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
|
|
US8354116B2
(en)
*
|
2007-06-18 |
2013-01-15 |
Biochemics, Inc. |
Bifunctional synthetic molecules
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
US7862877B2
(en)
*
|
2007-11-20 |
2011-01-04 |
Basic Electronics, Inc. |
Sanitary wrap
|
|
BRPI1007609A2
(pt)
|
2009-04-28 |
2016-02-16 |
3M Innovative Properties Co |
"adesivo sensível à pressão e dispositivo para aplicações de contato com a pele"
|
|
DE102010004950A1
(de)
*
|
2010-01-18 |
2011-07-21 |
Remis Gesellschaft für Entwicklung und Vertrieb von technischen Elementen mbH, 50829 |
Kühlregal mit Türvorrichtung
|
|
US8742022B2
(en)
|
2010-12-20 |
2014-06-03 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
US9296904B2
(en)
|
2010-12-20 |
2016-03-29 |
3M Innovative Properties Company |
Coating compositions comprising non-ionic surfactant exhibiting reduced fingerprint visibility
|
|
EP2729148A4
(en)
|
2011-07-06 |
2015-04-22 |
Parkinson S Inst |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
|
|
CN104662105B
(zh)
|
2012-06-19 |
2017-06-13 |
3M创新有限公司 |
包含表现出降低的指纹可见度的可聚合非离子型表面活性剂的涂料组合物
|
|
US9441135B2
(en)
|
2012-06-19 |
2016-09-13 |
3M Innovative Properties Company |
Additive comprising low surface energy group and hydroxyl groups and coating compositions
|
|
US10045935B2
(en)
|
2012-07-31 |
2018-08-14 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US11154535B2
(en)
|
2012-07-31 |
2021-10-26 |
Egis Pharmaceuticals Plc |
Transdermal formulation containing COX inhibitors
|
|
US9638452B2
(en)
*
|
2012-09-12 |
2017-05-02 |
Celltronix |
Method and scalable devices for hyper-fast cooling and warming
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
US8785426B1
(en)
|
2013-12-13 |
2014-07-22 |
Upsher-Smith Laboratories, Inc. |
Testosterone gel compositions and related methods
|
|
US11051516B2
(en)
*
|
2014-03-17 |
2021-07-06 |
Global Bioprotect Ip Pty Ltd |
Antimicrobial sanitizer compositions and their use
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
薬剤送達方法及びシステム
|
|
JP2018511127A
(ja)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
渇望入力及び支援システム
|
|
EP3565617A1
(en)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
AU2019279884B2
(en)
|
2018-05-29 |
2025-01-30 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
CA3119992A1
(en)
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
CN109700601B
(zh)
*
|
2019-02-02 |
2022-04-22 |
天津嘉氏堂科技有限公司 |
一种水胶体硅敷料贴
|